Insight on hepatitis B curative drug development with Dr. Mike Sofia
Listen now
Description
On this episode B Heppy we sit down with Dr. Mike Sofia, Co-founder and Chief Scientific Officer at Arbutus Biopharma to talk about his company's work on hepatitis B curative therapies. Listen and learn more about the pre-clinical process.  Resources: Arbutus Biopharma Drug Watch Clinical Trial Finder  Support the showOur website: www.hepb.org Support B Heppy! Social Media: Instagram - Twitter - Facebook
More Episodes
In this episode, Bright and Anousha invited Amy Jessop (Prevention Point) and Beatrice Zovich (Hepatitis B Foundation) to share insights from their recent study examining barriers to screening and education for hepatitis B and delta among PWUD (people who use drugs). Support the Show.Our website:...
Published 06/18/24
In this episode, Bright and Anousha interviewed Dr. Chari Cohen (President of the Hepatitis B Foundation), and Dr. Carolyn Wester (Director of the Division of Viral Hepatitis at the CDC). Dr. Cohen and Dr. Wester shared insights about the importance and impact of the universal hepatitis B...
Published 05/14/24
Published 05/14/24